 Double-blind placebo-controlled study therapeutic use recombinant human erythropoietin anemia chronic renal failure predialysis patients US Recombinant Human Erythropoietin Predialysis Study Group erratum Am Kidney Dis Sep seventeen patients anemia chronic renal failure severe maintenance dialysis recombinant human erythropoietin rHuEPO U/kg body weight IV times week weeks anemia Correction anemia hematocrit males females U/kg U/kg U/kg rHuEPO placebo group Energy levels work capacity group anemia group uncorrected anemia rHuEPO evidence therapy deterioration renal function serum creatinine reciprocal serum creatinine placebo treatment essential blood pressure hematocrit hypertensive patients development complications hypertension